Perspectives

The Cancer Revolution
Despite recent advances in the treatment of cancer, the disease remains a leading cause of death by disease worldwide1. It is reported that one in two people will be diagnosed with cancer in their lifetime2, resulting in a stronger-than-ever drive for new efficacious therapies. Our growing knowledge of cancer enables us to develop new technologies...
September 3, 2021
No Comments
APEIRON’s „Three questions to“
Prof. Josef Penninger 1. Do you remember your first "encounter" with the ACE2 molecule ? I remember well, it was in the hallway of the Ontario Cancer Institute. My postdoc Mike Crackower had just cloned the second ACE, hence ACE2. That was around 1998/1999. 2. Which physiological role does ACE2 have within the RAAS ?...
August 25, 2021
No Comments
APEIRON’s „Three questions to“
Prof. Chris Oostenbrink 1. How can computational techniques allow to study the effects of mutations of SARS-CoV-2 ? Computational methods allow us to describe molecular interactions at a space and time resolution that is often unattainable experimentally. This means that we can zoom in at an atomic level to understand visualize, rationalize, and predict what...
July 15, 2021
No Comments
APEIRON’s „Three questions to“
Prof. Ali Mirazimi, Karolinska Institutet, Department of Laboratory Medicine, Sweden 1. Given your background working with vaccines and contagious viruses, what surprised you most when the new coronavirus struck in March 2020 ? Most surprising was the broad arsenal of disease complexity and how the virus could very quickly cause a pandemic disease with huge...
June 14, 2021
No Comments
ACE2 – locking the door against coronaviruses?
Over a year after its emergence, COVID-19 continues to remain a global plague. Even with the development of vaccines, we see the pandemic caused by SARS-CoV-2 to stay with us for a while. With the identification of major new virus variants of concern hailing from the United Kingdom, South Africa, and Brazil with improved binding...
May 27, 2021
No Comments
SARS-CoV-2 and herd immunity – will the virus always be one step ahead ?
‘Herd immunity’ and vaccine strategy The concept of ‘herd immunity’ is massively important in terms of disease transmission and overall efficacy of vaccine strategies. It relies on a certain proportion of a population having immunity against a disease, thus protecting those who are unable to receive vaccines. If vaccinated individuals stop the spread of infection,...
April 14, 2021
No Comments
Reactivated immune cells of cancer patients (APN401) for the treatment of solid tumors
In light of the 21st annual #WorldCancerDay we would like to draw your attention to our work in fighting cancer. We at APEIRON Biologics AG want to make a contribution to people’s #wellbeing by developing the immune therapy APN401. APN401´s proprietary process brings in a paradigm change in cancer treatment to fight hematological and solid...
February 3, 2021
No Comments